Tradestie Institutional Equity Comparison Engine
OKUR vs LGND โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LGND Overall Edge
LGND Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ligand Pharmaceuticals Inc. (LGND) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, OKUR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus LGND at 24.0x Forward P/E and 14.4% operating margin (-31.8% YoY). In options structure, OKUR sits in SURGE (100th %ile IV; Dealer Gamma Walls on Pro) against LGND sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
LGND
OKUR N/M vs LGND 24.0x Fwd P/E
Growth & Margin Winner
LGND
Op Margin 0.0% vs 14.4% ยท YoY +0.0% vs -31.8%
Momentum & Technical Winner
LGND
1Y -2.2% vs +39.2% ยท 52W Pos 20% vs 74%
Options & Structure Winner
LGND
SURGE (100th %ile IV) vs CONSOLIDATION (9th %ile IV)
OKUR
NASDAQ
OnKure Therapeutics, Inc. Class A Common Stock
Pharmaceutical Preparations
$2.70
-2.17% 1D
Market Cap
$113.7M
1M Return
+4.65%
1Y Return
-2.17%
Forward P/E
N/M
Unified AI Score
36.0 / 100
SELL
Tech 20.0
Fund 46.0
Flow 64.0
Mom 60.0
LGND
NASDAQ
Ligand Pharmaceuticals Inc.
Pharmaceutical Preparations
$286.85
-0.03% 1D
Market Cap
$5.7B
1M Return
-6.81%
1Y Return
+39.21%
Forward P/E
24.0x
Unified AI Score
46.5 / 100
HOLD
Tech 32.0
Fund 49.0
Flow 67.0
Mom 56.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OKUR -2.17%
LGND +39.21%
Spread: +41.38 pp (LGND Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
OKUR TTM Op. Margin: 0.0%
LGND TTM Op. Margin: 14.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKUR vs LGND. Trailing 12-month operating profitability (OKUR 0.0% vs LGND 14.4%) and valuation multiples (OKUR N/M vs LGND 24.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OKUR | LGND | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $113.7M | $5.7B | Larger Scale | LGND |
| Trailing P/E Ratio Valuation | N/M | 115.2x | Lower Multiple | LGND |
| Forward P/E Ratio Valuation | N/M | 24.0x | Lower Multiple | LGND |
| Revenue Growth (YoY) Growth | +0.0% | -31.8% | Higher Growth | OKUR |
| Operating Margin (TTM) Profitability | 0.0% | 14.4% | Higher Margin | LGND |
| Net Profit Margin Profitability | 0.0% | 20.3% | Higher Margin | LGND |
| Return on Equity (ROE) Capital Efficiency | -55.2% | 5.4% | Higher ROE | LGND |
| 52-Week Range Position Momentum | 20% ($2โ$5) | 74% ($176โ$327) | Stronger Trend | LGND |
| Beta / 30D Volatility Risk Regime | 0.96ฮฒ ยท 100% Vol | 0.93ฮฒ ยท 38% Vol | Lower Realized Risk | LGND |
| Unified Institutional Score Composite Signal | 36.0 / 100 (SELL) | 46.5 / 100 (HOLD) | Higher Composite | LGND |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OKUR vs LGND Buy Guide
OKUR
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
LGND
CONSOLIDATION
102d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OKUR nor LGND registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.